Gratomic Inc released preliminary findings from its 5,000-meter diamond drill program on the Capim Grosso graphite project located in Brazil, which will further delineate graphite mineralization on a recently completed two-fold trenching and sampling program. The Toronto-based company said that two drill holes intercepted graphite varying in width from 0.1 meters to 11.15 meters. The aim of the drill program is to publish a maiden resource estimate, the exploration company said. Assay results from the first two drill holes will be announced when received and analyzed.
Empress Royalty Corp (TSX-V:EMPR, OTCQB:EMPYF) announced it has struck a US$15 million credit agreement with Nebari Natural Resources Credit Fund I LP. Nebari is a private fund focused on financing bespoke debt and convertible debt facilities for public and private companies within the resources sector. The Vancouver-based royalty and streaming company said it will use the accordion credit facility to help acquire new investments to add to its current 17-project portfolio.
Vuzix Corporation (NASDAQ:VUZI) announced that Case NewHolland (CNH) Industrial has deployed Vuzix M400 smart glasses within its CNH de Brazil group, across CNH and Iveco brands for training its product dealers throughout Latin America. The Rochester, New York-based company said that the local Vuzix distributor TotalPower supplied CNH with Wi-Fi routers and software in addition to Vuzix smart glasses." The use of Vuzix Smart Glasses for training continues to grow around the world as more and more enterprise customers understand and embrace the cost and productivity improvements this application offers," said Paul Travers, CEO of Vuzix in a statement. He added: "We are pleased to keep expanding our customer opportunities in South America through our distributor TotalPower and also to count industry leader CNH among the growing list of blue-chip companies that are embracing our technology."
Kontrol Technologies Corp (OTCQB:KNRLF, NEO:KNR) has told investors it is set to leverage its SmartSuite technology for Quebec's demand response energy market for use in commercial and multi-residential buildings. The tech group said it can integrate its SmartSuite solution with utilities that operate demand response programs through the use of application programming interface (APIs). "The demand response markets are growing rapidly across North America due to advancement of smart technologies, which utilities are increasingly leveraging for operating efficiency and resource allocation," said Paul Ghezzi, the CEO of Kontrol Technologies in a statement.
Boosh Plant-Based Brands Inc (CSE:VEGI, OTC:VGGIF) has highlighted a positive sales performance and said it added 75 new accounts in Canada, averaging 25 new stores every month over the past 90 days. The Vancouver, British Columbia-based company which through its subsidiary, Boosh Food, offers high quality, non-GMO, gluten-free, plant-based nutritional comfort foods, said it added two regional accounts in the shape of Natures Emporium in Ontario and Community Natural in Alberta. In terms of larger accounts, it added Thrifty Foods, thanks to which Boosh is now in the planogram for 28 stores in western Canada, a part of the Sobeys family of stores. It also added Metro Ontario and secured a retail price reduction on its bowls from $8.99 to $6.99. “It's anticipated this will accelerate sales and expand our consumer base,” said the company.
Todos Medical Ltd announced that its coronavirus (COVID-19) testing laboratory Provista Diagnostics has struck an agreement with a physician group that boasts a presence in over 40 states. The reference laboratory services agreement covers the semi-quantitative cPass neutralizing antibody test, which recently expanded upon its Emergency Use Authorization with the addition of semi-quantitative titer claims to be able to measure convalescent neutralization activity and provide a score to monitor over time. Provista has also completed the validation for a fingerprick at-home sample collection device for the cPass neutralizing antibody test.
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) announced that its subsidiary Altum Pharmaceuticals Inc has obtained non-dilutive financing from a key investor. The subsidiary inked an agreement with a European investor group to purchase up to US$5 million Altum shares by way of a non-brokered financing in tranches that will start in January 2022. Once the financing is completed, the investor group will own nearly 12.5% of Altum’s shares.
Milestone Scientific Inc (NYSE:MLSS) said that, following a successful trial, it has signed an agreement for the purchase of its CompuFlo Epidural and CathCheck Verification System disposables with a major Northeast teaching hospital. “We are honored to announce the adoption of our CompuFlo Epidural and CathCheck Verification System by yet another important and prestigious hospital,” said Arjan Haverhals, CEO of Milestone Scientific in a statement. He added: “This approval follows an extensive trial, which further validates the safety and efficacy of our technology. As a teaching hospital, our tools provide residents, fellows, and even seasoned physicians greater accuracy through real-time verification of epidural needle placement, as well as subsequent monitoring of catheter placement.”
Rio2 Ltd said it has closed the sale of the Anocarire mining concessions by Fenix Gold Ltda, a wholly-owned subsidiary of the company, to Andex Minerals Chile SpA following the successful completion of Andex's purchase option. In a statement, Jose Luis Martinez, Rio2's executive vice president and chief strategy officer, said: "The sale of this non-core asset adds an additional US$5,000,000 of available funding to support Rio2's strategic business initiatives other than the construction of the Fenix Gold Project which has its project financing arranged to production." The Anocarire mining concessions were one of the non-core assets resulting from the company's business combination with Atacama Pacific Corporation in July 2018.
Marble Financial Inc CEO Karim Nanji told shareholders that the firm plans to achieve “multiple catalysts” in the coming year by offering an alternative solution to mainstream financial services. The Vancouver-based company offers financial technology solutions underpinned by artificial intelligence. In a letter to shareholders, Nanji called 2021 a “transformational year” that saw the firm complete the acquisition of Inverite Verifications Inc and set new records in transaction volume and membership in its MyMarble platform.
SPYR (OTCQB:SPYR) Inc, doing business as SPYR (OTCQB:SPYR) Technologies, has announced that production of TV commercials for the company’s Applied MagixDrive wireless Apple CarPlay device has been completed and the initial round of 30 and 60 second commercials is scheduled for airing. SPYR (OTCQB:SPYR) said viewers will be able to order MagixDrive via a dedicated landing page at www.getmagixdrive.com and by phone at 800-714-8037. Both will go "live" before the commercials air.
Gevo Inc (NASDAQ:GEVO) has announced the hiring of Staci Bogue-Buchholz as the company’s new site and process optimization leader at its Luverne, Minnesota facility. Gevo said Bogue-Buchholz brings over 20 years of experience in plant management, strategic planning, major capital project leadership, and technical operations, most recently as head of engineering at VBTC Holdings.
Recruiter.com Group Inc said that it has released predictions for the 2022 job market as 2021 comes to a close after the unprecedented Great Recession. The New York-based recruiting solutions company said that the importance of talent will continue to grow in 2022 and employers will invest heavily in talent acquisition and retention. “Over the past few months, our Recruiter Index has shown that employees are prioritizing nontangibles more than ever. We saw a five percentage point increase in the number of employees who valued new experiences in the last month alone. The employees’ market is here to stay, and it’s time the employers start listening,” Recruiter.com CEO Evan Sohn said in the release.
Stifel GMP has reiterated a 'Buy' recommendation on HighGold (TSX-V:HIGH, OTCQX:HGGOF) Mining Inc after the company posted its latest drill assays from the high-grade Johnson Tract (JT) polymetallic gold project in Alaska, including one hole, which the company said would improve the current mineral resource. "The headline assay was 84.7m of 8.9 grams per tonne (g/t) AuEq from an infill hole in the upper part of the resource - higher grades than indicated by the block model," noted the Stifel analysts. "Infill drilling the down plunge portion of the deposit outside the resource envelope continues to define the deposit hitting multiple zones of mineralization, albeit at slightly lower grade thicknesses than we were expecting," they said.
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) said it has signed a letter of intent with Colorado-based Maya to develop a digital therapeutics platform for healthcare practitioners and patients. The agreement will enable Mydecine to enhance its existing Mindleap Health digital product to create more personalized treatments for patients. The new platform will allow physicians to prescribe new digital therapeutics as a standalone option or in conjunction with drug and therapy protocols. Denver-based Mydecine said that the move would improve the efficacy of the current treatment options, personalizing them and making them more accessible.
Victory Resources Inc told investors it has completed its previously announced extensive 45 kilometer (km) induced polarization (IP) survey at its Mal-Wen project in British Columbia and terminated its agreement with Silver Range Resources Ltd (TSX-V:SNG, OTC:SLRRF) over the Loner property in Nevada. Preliminary results from the survey at Mal-Wen indicate that two "significant" anomalies lie around 600 to 900 meters (m) east of the Mal prospect, and a 500m drill program is proposed to test these Mal East and far East anomalies. More drilling may also be recommended depending on the IP results from the southern half of the grid, which covers the Wen prospect, the firm added. "Victory leadership has determined that the company's resources should be allocated to the potential that exists with Smokey Lithium and Mal-Wen, versus devoting a further portion of time, expertise and capital to further exploration on Loner," said Mark Ireton, Victory's CEO in a statement. "In addition, the company is seeking and evaluating additional properties, especially those indicating lithium and related battery minerals," he added.
Mednow Inc (TSX-V:MNOW, OTCQB:MDNWF), a healthcare technology company, posted fiscal first-quarter results that saw its revenue jump 1,277.6% year-over-year as it builds its digital pharmacies and interdisciplinary model of care across Canada. For the period ended October 31, 2021, the Toronto-based company, which provides virtual pharmacy and telemedicine services, as well as doctor home visits, reported revenue of $570,343, compared to $41,400 in the fiscal first quarter of 2020. The company noted that the firm’s fiscal 1Q, 2022 revenue increased “over 4.5x quarter-over-quarter, and more than 13.5x year-over-year”. The growth follows the firm’s launch of Mednow Virtual Care in September 2021. The virtual care and telemedicine services platform, facilitated through the Mednow web and mobile application, is currently available in Ontario and will expand its coverage to serve patients across Canada in 2022, said Mednow.
Harbor Custom Development Inc has announced the sale of 24 developed lots in the Horizon at Semiahmoo subdivision in Blaine, Washington, to MainVue Homes for $4.8 million. The transaction includes 71 developed lots with panoramic views of Birch Bay and the Cascade Range and is situated adjacent to the Semiahmoo Resort and award-winning golf course. Harbor purchased the 219-acre Horizon subdivision in July 2021. “We welcome MainVue Homes to the Horizon at Semiahmoo project and look forward to working with them as one of our select builders in this beautiful Horizon subdivision,” Harbor CEO Sterling Griffin said in a statment. “MainVue is an established luxury brand in the Pacific Northwest and is ideally suited to bring their unique design and craftsmanship to Horizon.”
Co-Diagnostics (NASDAQ:CODX) Inc announced that it has signed agreements to acquire Idaho Molecular Inc and Advance Conceptions Inc for the development of its upcoming at-home/point-of-care diagnostic device. The Utah-based company said that the transactions will provide it with all the existing and future assets and intellectual property related to the upcoming platform. "The company expects that the acquisition will streamline the commercialization of the Eikon™ platform and YourTest™ PCR device as it nears completion and prepares for a market release with an easy-to-use sample-to-result COVID-19 test," Co-Diagnostics (NASDAQ:CODX) (Co-Diagnostics (NASDAQ:CODX)) said in a statement. It noted that the terms include the issuance of nearly 4.72 million shares of its stock, including those shares provided as incentives to encourage efficient and timely completion of development and manufacturing milestones, plus additional common warrants totaling 465,000. The closing of the agreement is expected before the end of the year 2021.
Global Energy Metals Corp (TSX-V:GEMC) said 2021 has been a foundation year as the company continues to advance its portfolio of battery metals projects as the globe turns to a greener, more electric, future. In a year-end update, GEMC CEO Mitchell Smith said 2022 will see the company continue to focus its efforts on jurisdictions, which are supportive of mining, and on deposit styles that deliver the bulk of the world's cobalt, copper and nickel. "We seek to play a strong role in the energy transition movement by providing the metals needed to disconnect from fossil fuels, and enable renewable power and electric mobility that supports a lower carbon economy," he added.
The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc said it has entered into a manufacturing partnership with Montreal Cannabis Médical Inc (MTL) to provide manufacturing and extraction services for MTL's pre-rolls and vapes. Valens noted it expects the contract to begin at the end of the first quarter of fiscal 2022.
Cypress Development Corp (TSX-V:CYP, OTCQB:CYDVF) has reported a successful seven-day continuous test run at its pilot plant in Nevada and the extension of its lease at the facility to 2025. Earlier this month, the company reported the successful start-up at the plant, which is extraction testing lithium-bearing claystone from its Clayton Valley lithium asset. During the seven days, the plant operated at its designed feed rate of one ton per day of lithium claystone, noted the company. "From an operating perspective, we are very pleased with how the pilot plant has performed to date," said Bill Willoughby, the CEO of Cypress Development in a statement.
American Manganese Inc, the company which upcycles lithium-ion battery waste into battery materials, has outlined its key achievements in 2021, which included raising C$20 million via a placing and laying the foundations for continued growth in 2022. The company's CEO, Larry Reaugh said there had been progress on multiple fronts, noting that its RecycLiCo and Wenden projects had demonstrated their added value and differentiation in the cleantech and battery metals market. "Our financing highlights also represent an important milestone that enhances our ability to execute on our growth strategy," he added in the year-end statement.
CLS Holdings USA (CSE:CLSH, OTCQB:CLSH) (CLS Holdings USA (CSE:CLSH, OTCQB:CLSH), CLS Holdings USA (CSE:CLSH, OTCQB:CLSH)) Inc announced that its subsidiary City Trees has nabbed first place in two categories at the 2021 High Times Cannabis Cup: People’s Choice Edition. The cannabis brand won the Sativa Concentrates: Apricot Crumble Sativa Live Resin Sauce, and Sativa Vape Pens: Apricot Crumble Sativa Live Resin Vape categories. City Trees is no stranger to awards recently, having been named the top-performing brand in Nevada by Leaflink in November, and fastest-growing THC Distillate and top-selling THC Distillate in Leaflink List, 2021 in the concentrate category.
Potent Ventures Inc has announced that it will change its name to The Gummy Project, with a new stock symbol GUMY. "The name and ticker change are necessary as part of the overall proposed rebranding process and to accurately reflect what we expect our primary business strategy to be moving forward and our portfolio of products," said Charlie Lamb, president and CEO of the company. The company said it expects the name change and ticker change to become effective upon the Canadian Securities Exchange approving the "listing statement" and the "change of business" being approved by shareholders. The company will continue to trade under the CSE stock symbol POT until the effective date.
Avalon GloboCare Corp (NASDAQ:AVCO) has announced that the company’s chairman, Daniel Lu, has converted $3.0 million of debt owed to him under the Line of Credit into 2.4 million shares of the company’s common stock at $1.25 per share. The conversion price represents a 45% premium to yesterday’s closing price. “We are grateful for our Chairman’s continued support and tremendous confidence in the outlook for the business, as illustrated by his willingness to convert his loan at a significant premium to market, thereby further strengthening our balance sheet,” said Dr David Jin, president and chief executive officer of Avalon. “We continue to make rapid progress advancing our immune effector cell therapies, including CAR-T and CAR-NK, our S-layer coated emulsome technology (SLET), our exosome-based regenerative therapeutics (ACTEX), as well as our liquid biopsy diagnostic and drug delivery platforms. Importantly, we look forward to reporting a number of important milestones that we believe will drive significant shareholder value heading into the new year.”
SoLVBL Solutions Inc has announced that after successfully completing the application process, the company has received approval from OTC Markets Group Inc. (OTCQX:OTCM) for its common shares to begin trading on the OTCQB Market under the symbol SOLBF. The company's common shares will remain listed on the CSE in Canada under the ticker symbol SOLV. The OTCQB is a transparent trading platform that offers a cost-effective method for United States investors to access SoLVBL's securities. SoLVBL's quotation and trading on the OTCQB provides investors the opportunity to benefit from streamlined market standards which enhance the availability of information to the general public, enabling greater transparency.
CytoDyn Inc has announced that the US District Court for the District of Maryland has granted the company’s previously-announced motion for a preliminary injunction against NSF International, Inc. and its subsidiary Amarex Clinical Research, its former Contract Research Organization (CRO). Over the past eight years, Amarex provided clinical trial management services to CytoDyn and managed numerous clinical trials. The company’s complaint alleged that Amarex failed to perform its obligations under the master services agreement and work orders that governed the relationship between the parties. As a result, the company suffered substantial damages. The Court concluded that the company was likely to succeed on its claims that Amarex breached the various agreements with CytoDyn, and therefore entered an injunction requiring Amarex to provide CytoDyn access to databases of its clinical trial data that Amarex has been wrongfully withholding. Additionally, the order is subject to the company posting a $6.5 million bond no later than January 14, 2022. Dr Nader Pourhassan, CytoDyn’s president and chief executive officer, commented: “We are pleased with the Court’s ruling and are focused on the positive momentum of our pipeline. It is gratifying to see that Amarex will be held accountable for its numerous shortcomings in delaying the potential of the availability of leronlimab to thousands of patients for multiple indications. By doing so, we believe they also harmed our shareholders. Upon completion of our court-granted audit, if any damages are discovered which are due to negligence on behalf of Amarex, we will aggressively pursue all and any legal action.”
Binovi Technologies Corp said it has appointed David Jenkins to its board of directors. Jenkins is a global financier who works with high-net-worth individuals. He has extensive experience in public markets, and has helped secure millions of dollars in capital in private and public sectors. He is a highly regarded expert in negotiating, marketing and advertising. He has completed hundreds of multimillion-dollar deals throughout his career, demanding top price for assets in all market conditions. Jenkins brings in-depth market knowledge and experience to the company, Binovi said. The company also announced the resignation of Jason R.B. Dyck as a director and said it thanked him for his efforts and wished him continued success with his future endeavours.
Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 100,000 common share purchase warrants, with each warrant being exercisable into one common share of the company at a price of 39 cents over a two-year period, in connection with a consulting services agreement with an arm's-length consultant.